Monoclonal Antibody Therapy in the Treatment of Non-Hodgkin Lymphoma

Monoclonal antibodies are revolutionizing the treatment of many illnesses; they typically either harness the patient's own immune system to fight disease or suppress an errant immune system. McCune et al focus on the use of monoclonal antibodies for the treatment of patients with non-Hodgkin�...

Full description

Saved in:
Bibliographic Details
Published inJAMA : the journal of the American Medical Association Vol. 286; no. 10; pp. 1149 - 1152
Main Authors McCune, Steven L, Gockerman, Jon P, Rizzieri, David A
Format Journal Article
LanguageEnglish
Published Chicago, IL American Medical Association 12.09.2001
Subjects
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antineoplastic agents
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Hematologic and hematopoietic diseases
Humans
Immunoconjugates
Immunotherapy
Immunotoxins
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma
Lymphoma, Non-Hodgkin - therapy
Medical sciences
Pharmacology. Drug treatments
Radioimmunotherapy
Therapy
Human
Toxicity
Malignant hemopathy
Monoclonal antibody
Review
Non Hodgkin lymphoma
Biological activity
Chemotherapy
Treatment
Lymphoproliferative syndrome
Immunotherapy
Adult
Combined treatment
Online AccessGet full text

Cover

More Information
Summary:Monoclonal antibodies are revolutionizing the treatment of many illnesses; they typically either harness the patient's own immune system to fight disease or suppress an errant immune system. McCune et al focus on the use of monoclonal antibodies for the treatment of patients with non-Hodgkin's lymphoma.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.286.10.1149